EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BRCA1 Promoter CpG Methylation in Breast Cancer: A Pilot Study in African Women

Tarryn Willmer iD, Mpoi Makhetha iD, Ayesha Rasheed Shaik, Lawrence Mabasa iD, Ines Buccimazza iD, Colleen Aldous

Genes · 31.03.2026 · 17 (4) · 407

DOI: 10.3390/genes17040407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 31.03.2026. Verfasst von Tarryn Willmer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa. Hauptthemen laut MEDLINE: DNA Methylation, Promoter Regions, Genetic, CpG Islands, BRCA1 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, South African Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer susceptibility gene 1 (BRCA1) is a pivotal regulator of DNA repair, and its loss through germline mutations is strongly linked to the development of aggressive breast cancers with characteristic clinical and pathological features. Beyond genetic disruption, epigenetic silencing via promoter hypermethylation has emerged as a non-mutational mechanism of tumour suppressor inactivation and a potential biomarker for guiding therapeutic decisions. Here, we investigate BRCA1 promoter methylation, its impact on gene expression, and its association with clinicopathological features in a cohort of African women with breast cancer.

Methods

Matched tumour and adjacent normal tissues from 27 Black African women with breast cancer were analysed for BRCA1 promoter methylation and gene expression using bisulfite pyrosequencing and quantitative real-time PCR. Associations with clinicopathological variables were assessed using Spearman’s correlation analyses.

Results

Five CpG sites within the BRCA1 promoter were significantly hypermethylated in breast tumours compared with matched adjacent normal tissues and showed an inverse association with BRCA1 mRNA expression. Elevated promoter methylation was enriched in hormone receptor-negative and triple-negative breast cancer subtypes and was not influenced by neoadjuvant chemotherapy. BRCA1 promoter methylation occurred independently of BRCA1 mutational status. No significant associations were observed between BRCA1 methylation and age, body mass index, smoking status, or alcohol consumption.

Conclusions

Our findings provide evidence of BRCA1 epigenetic silencing in breast tumours from African women, particularly within aggressive hormone receptor-negative subtypes. These results suggest that BRCA1 promoter methylation may represent a clinically informative biomarker for patient stratification and highlight the importance of validation in larger, population-representative cohorts before clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationPromoter Regions, GeneticCpG IslandsBRCA1 ProteinBreast NeoplasmsHumansFemalePilot ProjectsMiddle AgedAdultGene Expression Regulation, NeoplasticEpigenesis, GeneticBlack PeopleBiomarkers, Tumor

Stichwörter der Autor:innen

AfricansBRCA1DNA methylationbreast cancerepigenetic biomarkers

Substanzen

BRCA1 ProteinBRCA1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
  • Centre for Cardio-Metabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg 7505, South Africa.
  • Division of Cell Biology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.
  • Department of Clinical Medicine, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.
  • Department of Oncology, Inkosi Albert Luthuli Central Hospital, Durban 4091, South Africa.

ORCID-Profile: Tarryn Willmer, Mpoi Makhetha, Lawrence Mabasa, Ines Buccimazza

Förderung

  • National Research Foundation
  • South African Medical Research Council

Zitieren

APA

Willmer, T., Makhetha, M., Shaik, A. R., Mabasa, L., Buccimazza, I., & Aldous, C. (2026). BRCA1 Promoter CpG Methylation in Breast Cancer: A Pilot Study in African Women. Genes, 17(4), 407. https://doi.org/10.3390/genes17040407

Vancouver

Willmer T, Makhetha M, Shaik AR, Mabasa L, Buccimazza I, Aldous C. BRCA1 Promoter CpG Methylation in Breast Cancer: A Pilot Study in African Women. Genes. 2026;17(4):407. doi:10.3390/genes17040407

BibTeX
@article{Willmer2026,
  author = {Willmer, Tarryn and Makhetha, Mpoi and Shaik, Ayesha Rasheed and Mabasa, Lawrence and Buccimazza, Ines and Aldous, Colleen},
  title = {BRCA1 Promoter CpG Methylation in Breast Cancer: A Pilot Study in African Women},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {407},
  doi = {10.3390/genes17040407}
}
Kostenlos starten →